Hsiri Therapeutics, LLC
Hsiri is a start-up antibiotics company founded by two seasoned pharma executives with novel antibiotics from Dr. Marvin Miller at the University of Notre Dame.
Hsiri is developing new antibiotics in areas where bacterial resistance is a significant concern. Major pharmaceutical companies are not investing in antibiotic research. Initially, we intend to develop our compounds for licensing to these companies and other, emerging, mid-sized pharma. Ultimately, however, we intend to market one or more of the Hsiri products in niche markets with our own marketing and sales organization.